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Abstract 
Background 
Socioeconomic deprivation (SED) influences likelihood of pre-emptive kidney 
transplantation (PET), but the mechanisms behind this are unclear. We explored the 
relationships between SED and patient characteristics at referral, which might explain 
this discrepancy. 
Methods 
A retrospective cohort study was performed. SED was measured by Scottish Index of 
Multiple Deprivation (SIMD). Logistic regression evaluated predictors of PET. A 
competing risks survival analysis evaluated the interaction between SED and 
progression to end stage kidney disease (ESKD) and death. 
Results 
Of 7,765 patients with follow-up of 5.69±6.52 years, 1,298 developed ESKD requiring 
RRT; 113 received PET, 64 of which were from live donors. Patients receiving PET 
were ‘less deprived’ with higher SIMD (5±7 vs 4±5; p=0.003). This appeared 
independent of overall comorbidity burden. SED was associated with a higher risk of 
death but not ESKD. Higher SIMD decile was associated with a higher likelihood of 
PET (OR 1.14, 95% CI 1.06, 1.23); the presence of diabetes and malignancy also 
reduced PET.  
Conclusions 
SED was associated with reduced likelihood of PET after adjustment for baseline 
comorbidity, and this was not explained by risk of death or faster progression to ESKD. 
Education and outreach into transplantation should be augmented in areas with higher 
deprivation.  
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Introduction 
Socioeconomic factors have repeatedly been shown to influence management 
strategies in end stage kidney disease (ESKD) [1-3], however the mechanism behind 
these associations remains elusive. 
Pre-emptive kidney transplantation (PET) whereby the patient receives a kidney 
transplant as first modality of renal replacement therapy (RRT), remains the optimal 
treatment of EKSD which improves patient and transplant outcomes by avoidance of 
a preceding period of dialysis and is recommended in all suitable patients by national 
guidance [4, 5]. Certain medical factors prove relative or absolute contraindications to 
transplantation, such as the presence of cardiovascular disease, peripheral vascular 
disease or a history of malignancy [6]. Timing of referral to nephrology services, and 
system factors within the transplant evaluation process, also influence the likelihood 
of a recipient being determined suitable for transplantation prior to the need for an 
alternative form of RRT [7]. Access to a live donor also increases the likelihood of PET, 
given that median waiting time on the deceased donor renal transplant list is greater 
than 3 years [8].  
However, non-medical factors have been found to affect modality of RRT, creating 
inequity even within universal healthcare systems such as the United Kingdom. A 
recent prospective study demonstrated an association between various stigmata of 
socioeconomic deprivation (SED), such as level of education and car ownership, and 
live donor transplantation [3], which reflects findings in other healthcare scenarios 
such as in the United States [9] and Australia [10]. In contrast, a prospective multi-
centre study of potential live donor assessment in the United Kingdom found no 
association between likelihood of successful donation and SED [11]. The mechanism 
by which SED leads to a discrepancy in RRT provision therefore remains elusive and 
may in part relate to recipient engagement and empowerment [12], as well as financial 
factors, such as transport to aspects of transplant evaluation or provision of income 
after live donor transplantation.   
Nevertheless, the possibility that the discrepancy in RRT provision relates to 
differences in progression to ESKD has not been excluded. For example, patients of 
lower socioeconomic status may have greater mortality due to comorbid factors which 
remain important predictors of outcome despite the differences in cardiovascular 
disease in EKSD [13], and the competing risk of death may confound the interpretation 
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of RRT rates. Alternatively, patients with SED may be referred at a later stage of renal 
impairment, or may undergo faster progression to ESKD, both of which may hinder 
transplant evaluation and listing, or identification and assessment of potential live 
donors. There has been little longitudinal investigation into the association between 
SED and PET with regards to the factors associated with healthcare status and risk of 
progression to ESKD at the first assessment at the nephrology clinic.  
We therefore investigated the predictors of RRT modality in patients with incident 
ESKD, focusing on the effect of SED on pre-emptive kidney transplantation.  
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Materials & Methods 
Study design and population 
A retrospective single centre cohort study was performed, of a prospectively obtained 
database of adult patients with chronic kidney disease (estimated glomerular filtration 
rate (eGFR) below 60ml/min/1.73m2). Patients were included whom attended general 
nephrology clinics in NHS Greater Glasgow and Clyde between 2006 – 2016, with 
follow up extended to 2017 (see supplementary online material). Individuals 
approaching the live kidney donor evaluation process were also included for a 
separate analysis, investigating the association between deprivation and successful 
live kidney donation. Data were obtained from the Strathclyde Electronic Renal Patient 
Record (SERPR, VitalPulse, UK) which includes description of primary renal 
diagnosis, demographics, comorbidity, dates of outpatient attendances, biometric 
measurements made at outpatient attendances, as well as biochemistry. Data 
regarding the date and modality of first RRT are also recorded. Measurements of 
serum creatinine and urinary protein to creatinine ratio (uPCR) were performed in 
standard accredited hospital biochemistry departments. Measurements were obtained 
at time of referral to the nephrology clinic and prior to the onset of RRT. eGFR was 
calculated from serum creatinine using the CKD-EPI formula [14] using the average 
of three sequential creatinine values from time of first clinic visit. Comorbidities were 
recognised if they were diagnosed prior to the onset of ESKD.  
Socioeconomic deprivation 
The Scottish Government provide online lookup files allowing use of patient postcode 
to generate an urban-rural classification[15] and divisions of socioeconomic 
deprivation, the Scottish Index of Multiple Deprivation (SIMD) [16]. The SIMD is a 
measure of relative deprivation, where postcodes are ranked on multiple domains 
including income, employment, education, health, access to services, crime and 
housing. An aggregate score is calculated, and each postcode ranked in order, to 
allow deciles to be calculated from the most (SIMD = 1) to least deprived (SIMD = 10). 
The SIMD has been used for the purposes of biomedical research in other studies 
previously and is felt to be a robust method of evaluating deprivation by geographical 
area [17-20]. For the purposes of a grouped survival analysis, the study population 
was numerically halved at the median SIMD by dichotomising into SIMD less than or 
equal to three, and SIMD greater than three. 
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Comorbidity 
From the renal electronic patient record, we derived specific major comorbidities which 
may preclude or hinder progress towards transplantation, namely cardiovascular 
disease, malignancy and diabetes. Additionally we have derived a quantitative 
comorbidity score which is derived from a range of conditions, namely the Charlson 
comorbidity index [21], which has been validated in a series of populations [22, 23]. A 
survival analysis was performed to confirm an association between quartiles of 
comorbidity index and overall mortality. The Charlson comorbidity score itself was then 
entered into the logistic regression model in order to adjust for differences in baseline 
morbidity between socioeconomic groups.  
Statistical analysis 
Summary data are expressed as mean ± standard deviation, or median ± interquartile 
range where data are not normally distributed, whilst groups are compared using 
Student’s t test or Wilcoxon’s test. A competing risks survival analysis was conducted 
within the entire dataset to evaluate the progression to ESKD and death, with the first 
assessment at nephrology clinic representing the time of origin. A competing risks 
regression analysis was conducted with both the Fine and Grey’s subdistribution 
hazards and cause specific hazards models. The variables associated with PET were 
evaluated in a logistic regression analysis, within the cohort of patients reaching 
ESKD. Regression analyses were carried out on datasets with missing data imputed 
by chained equations [24]. Five datasets were imputed from the original data, and an 
initial univariate regression analysis was carried out including variables which have 
previously been shown to associate with PET. All variables had less than 5% missing 
data apart from body mass index (BMI), which was therefore excluded from the 
imputation model. Stepwise variable selection was then carried out and this model 
applied to each imputed dataset in turn, before the model was pooled across the 
imputed datasets; the described results, including the McFadden’s pseudo R2, 
therefore represent the model pooled across the five imputed datasets. Statistical 
analysis is performed using R Studio version 1.1.383 running R version 3.4.2, with the 
mice, riskregression, ggplot2, forestplot, and cmprsk, and cr17 packages. Use of 
anonymised data from this database has been approved by the West of Scotland 
Ethics Committee via the NHS Greater Glasgow and Clyde ‘Safe Haven’ data for 
research group. 
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Results 
Baseline characteristics 
Of an initial dataset of 7,765 patients with chronic kidney disease (CKD) and a median 
follow-up time of 5.69±6.52 years, 1,298 patients developed ESKD requiring RRT (see 
supplementary online material). Of those who received RRT, 113 received PET, 64 of 
which were obtained from live donors; 1006 received in hospital haemodialysis (HD), 
13 home HD, and 166 peritoneal dialysis (PD). Of the live donors, 23 were received 
from a partner, 19 from a sibling, 10 from a parent, 3 were altruistic and 9 were from 
other donors. Distribution of SIMD is shown in supplementary online material. 
Characteristics of those reaching ESKD and receiving PET 
In comparison to those not requiring RRT, patients who developed ESKD had lower 
body mass index (BMI) (27.5±8.6 vs 28.6±7.6 kg/m2; p<0.001), and were referred 
younger (56.4±26.2 vs 70.7±17.2 years; p<0.001), with lower eGFR (31.2±27.1 vs 
37.5±22.3 ml/min/1.73m2; p<0.001), higher blood pressure (BP) (150/82±34/18 vs 
147/76±34/19 mmHg; p=0.004) and uPCR(156.3±310.3 vs 43.8±106.3 mg/mmol; 
p<0.001). There was no difference in SIMD decile (4±5 vs 4±5; p=0.60). There was 
lower prevalence of cardiovascular disease (21 vs 32%; p<0.001) and malignancy (11 
vs 17%; p<0.001) in the group reaching ESKD, but no difference in the prevalence of 
diabetes (35 vs 37%; p=0.39) (table 1). 
Patients who received a pre-emptive transplant had higher SIMD decile (5±7 vs 4±5; 
p=0.003), lower BMI (25.6±6.6 vs 27.7±8.7 kg/m2; p=0.003), and were referred 
younger (36.5±19.5 vs 58.4±24.2 years; p<0.001), with higher eGFR (39.7±39.8 vs 
30.6±26.2 ml/min/1.73m2; p=0.001), lower blood pressure (BP) (138/82±32/17 vs 
150/82±34/18 mmHg; p<0.001), and uPCR (93.2±184.8 vs 168.7±326.4 mg/mmol; 
p<0.001). There was a lower prevalence of cardiovascular disease (6 vs 22%; 
p<0.001), diabetes (15 vs 37%; p<0.001) and malignancy (3 vs 12%; p=0.004). 
Comorbidity score was lower in the group proceeding to PET compared to other RRT 
modalities (2 ± 1 vs 4 ± 3; p<0.001). The time between referral and ESKD was longer 
(8.7±12.1 vs 4.9±7.2 years; p<0.001) and RRT was commenced at a higher eGFR in 
the PET group (9.3±5.7 vs 7.04±3.8 ml/min/1.73m2; p<0.001) (table 1). 
Characteristics of patients from lower SIMD decile 
Patients from SIMD≤3 had higher BMI (29.0±8.4 vs 28.1±7.3 kg/m2; p<0.001), and 
were referred younger (68.7±19.0 vs 69.3±19.1 years; p=0.02), with higher uPCR 
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(57.0±192.2 vs 51.7±130.4 mg/mmol; p=0.003), albeit with no difference in referral 
eGFR (37.0±22.8 vs 36.3±23.1 ml/min/1.73m2; p=0.18) or BP (148/77 ±34/19 vs 
148/78±35/18 mmHg; p=0.69). There was a higher prevalence of cardiovascular 
disease (32 vs 28%; p<0.001), diabetes (38 vs 35%; p=0.001) and lower prevalence 
of malignancy (15 vs 17%; p=0.01). There was no difference in baseline comorbidity 
score between the two socioeconomic groups (6 ± 3 vs 5 ± 3; p=0.98) (table 2).  
Patients with SIMD≤3 who progressed to ESKD had a higher utilisation of hospital HD 
(84 vs 72%; p<0.001), and lower prevalence of PD (9 vs 17%; p<0.001) and transplant 
(6 vs 10%; p=0.02) as first RRT method.  
Association between socioeconomic status and survival 
Cumulative incidence curves displaying the association between SED and 
progression to death and ESKD are shown in figure 1. Patients from SIMD≤3 had a 
greater likelihood of death (log rank p<0.001) but not ESKD (log rank p=0.33). 
The factors associated with the outcomes of death and ESKD are described in table 
3. Covariables which were associated with an increased hazard of death were lower 
SIMD decile, cardiovascular disease, malignancy, diabetes, older age and higher 
uPCR at referral, and lower eGFR and BP at referral. The covariables which were 
significantly associated with an increased risk of ESKD were diabetes, higher systolic 
BP and uPCR at referral, and lower eGFR and age at referral; the presence of 
cardiovascular disease and malignancy were associated with a lower hazard of ESKD.  
Factors influencing pre-emptive kidney transplantation 
The covariables associated with a higher likelihood of receiving PET were analysed in 
a multiple logistic regression analysis (table 4). Higher SIMD decile was associated 
with a higher likelihood of PET; the presence of diabetes, malignancy, higher referral 
eGFR, age, and uPCR were associated with a lower likelihood of PET (McFadden’s 
pseudo R2 = 0.20; p<0.001) (figure 2). 
In a survival analysis, quartile of comorbidity score was significantly associated with 
overall survival (see supplementary online material). The comorbidity score was then 
entered into the logistic regression model in place of the specific comorbidities used 
in the previous analysis. Higher SIMD remained associated with a higher likelihood of 
PET (McFadden’s pseudo R2 = 0.19; p<0.001) (figure 2). 
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Association between socioeconomic deprivation and live kidney donation 
Given that SED was associated with reduced live kidney donation, we evaluated the 
relationship between deprivation and successful live kidney donation. Between 2009 
and 2018, 1208 potential live donors (PLDs) were evaluated with age of 45.8 ± 21.4 
years, follow-up 3.4 ± 8.5 months and SIMD of 4 ± 5. There was no association 
between deprivation and likelihood of successful donation (8 vs 11%; p=0.13), and 
neither was there a difference in the cumulative incidence of successful donation 
between groups (log rank p=0.27) (see supplementary online material).  
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Discussion 
The UK National Institute for Clinical Excellence (NICE) guidelines suggest that PET 
is the optimal treatment modality for medically suitable patients [5], given that time on 
dialysis is one of the most significant modifiable factors relating to both transplant 
outcomes [4] and the development of cardiovascular disease [25]. Additionally, 
avoidance of dialysis prior to transplant prevents the need for vascular access 
procedures which may broaden longer term RRT options. Previous work has shown 
that access to both transplant and other home modalities of RRT is not equitable 
however, with socioeconomic [12] and ethnic [26, 27] factors affecting RRT choice in 
addition to medical factors. 
The incidence of PET was lower in those from lower SIMD decile, and on multiple 
regression analysis, for each increment in SIMD decile, the incidence of patients 
receiving PET was increased by 14%. Data from other studies into the effect of SED 
on transplantation has been conflicting; in Australia, the rates of living but not 
deceased renal transplantation is reduced by SED [10], whilst in the United States 
patients from deprived backgrounds have lower rates of deceased donor, live donor, 
and pre-emptive transplantation [28]. Incidence of deceased donor transplantation is 
also altered by ethnicity in the United States, with the lowest rates in native American 
and black populations.  In the United Kingdom, factors relating to SED [2] and dialysis 
centre [7] are associated with deceased and live kidney donation. Whilst ethnicity has 
not been found to be associated with wait listing in the United Kingdom [2], patients 
from ethnic minority groups are less likely to receive a live versus deceased donor 
transplant [3]. The reasons behind this are complex and involve several factors 
including unintentional bias amongst healthcare teams, differences in cultural 
acceptability of kidney donation, and variation in the distribution of morbidity in 
potential donors which may preclude donation. Using the granularity of the electronic 
renal database from which the data are derived, we investigated the mechanisms 
behind this association, with the hypothesis that deprivation may lead to later referral 
to nephrology services or a disparity in progression to ESKD.   
Evaluation of baseline parameters at time of referral to the nephrology clinic 
demonstrated little difference between the two SIMD groups. Whilst proteinuria was 
greater in the more deprived group they differed by such a small degree that it would 
be deemed clinically insignificant; eGFR was no different between groups, and 
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patients from lower SIMD decile were in fact referred at a slightly younger age. The 
referral characteristics of the group from lower socioeconomic status did not therefore 
explain the gap in PET.  
Evaluation of our entire cohort of patients with CKD allowed a competing risks survival 
analysis of the progression to ESKD, to determine if this accounted for the discrepancy 
in RRT provision between socioeconomic classes. In a competing risks analysis, 
patients are censored if a certain outcome develops prior to, and at the cost of, the 
outcome of interest; this is in contrast to a traditional (for example Kaplan-Meier) 
survival analysis which allows for only a single outcome. In our analysis, lower SIMD 
decile was associated with an increased hazard of death both in univariate and 
multivariate analysis. Despite this, the hazard of ESKD was no different from those in 
higher socioeconomic class, and even after adjustment for baseline characteristics in 
a multivariate analysis, there was no independent association between deprivation 
and a difference in progression to ESKD.  
We found no evidence therefore, that patients from lower socioeconomic class are 
referred at a later stage of CKD or progress to ESKD at a significantly quicker rate, 
and neither does the competing risk of death act as a confounder in the interpretation 
of the data. It is notable however that those receiving PET were referred at a higher 
eGFR and younger age; although there was no difference in stage of CKD in which 
patients were referred, earlier referral of patients with lower socioeconomic status may 
represent a mechanism by which the deficit of PET can be reduced.     
In UK practice the recent landmark Access to Transplantation and Transplant 
Outcome Measures (ATTOM) study has dissected out many of the interactions 
between SED and live donor transplantation [3]. In addition to confirming many of the 
conclusions of previous registry studies, ATTOM explored the association between 
transplantation and the attributes comprising social status, such as literacy and car 
ownership. Indeed, lower educational attainment increased the time to be added to 
the transplant waiting list and to living donor transplant by 22% and 47%, respectively 
[29]. Car ownership may also directly affect transplantation prospects by limiting 
access to hospital-based assessment clinics, and by limiting attendance of potential 
live donors to low clearance clinics. Using SIMD, a postcode of residence-based tool, 
to assess SED has limitations, in that generalisations are made about individual 
patients and postcodes. It is possible that outliers exist within a postcode, with affluent 
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patients living in areas with high deprivation, and vice versa. This can introduce 
inaccuracy when using such methodology to evaluate individual outcomes. 
Nevertheless, there are advantages to its use in health records-based research, such 
as its ready availability, reproducibility, and links to other encounters with healthcare, 
which also allowed comparisons with a large group of controls who did not reach 
ESKD, or who received a different form of RRT.  
It is widely accepted that deprivation is associated with an increased prevalence of 
cardiovascular disease, diabetes, and many other conditions [30], which is reflected 
in our data by the higher prevalence of cardiovascular disease and diabetes in this 
group of patients with CKD. Extended to the donor pool, given that potential live donors 
likely share socioeconomic factors with their recipients, these factors may limit the live 
donation in patients with SED thereby limiting the likelihood of PET. Certainly, live 
donation was less common in the cohort with SED, which partly explains the gap in 
pre-emptive transplantation. We also examined participants approaching our live 
donor evaluation process, and examined the association between successful donation 
and SED. We found no interaction between low SIMD and successful donation. This 
was reflected in a recent prospective analysis of potential live donor assessment found 
no interaction between deprivation and likelihood of successful donation [11], data 
which encourage researchers to look elsewhere for reasons behind the discrepancy 
in transplant provision.  
Our study has several limitations which must be acknowledged. Firstly, the 
retrospective analysis of routinely collected data, albeit prospectively acquired, can 
introduce bias via incomplete recording of patient data, although conversely, the study 
design allows for a comprehensive evaluation of real world RRT practice. Given the 
difference in baseline comorbidity between socioeconomic groups, we performed a 
logistic regression analysis to adjust for this, to measure the specific effect size of 
differences in socioeconomic status. Although this is a conventional practice, it is 
possible that this did not fully account for differences in baseline comorbidity and 
residual confounding persists. Furthermore, the study pertains to a single transplant 
centre, and the findings may not be widely applicable. The electronic database from 
which data are derived does not record ethnicity, which has previously been shown to 
be a determinant of RRT choice and may confound the relationship between 
deprivation and RRT. The study cohort is fairly racially homogeneous however, with 
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only 5.3% of the West of Scotland population from non-white ethnic backgrounds [31]. 
Whilst on average there is greater SED in black and middle eastern populations, there 
is clearly a complex relationship between ethnicity and socioeconomic status which 
makes it difficult to fully define the independent relationship between ethnicity and 
transplantation [32]. Finally, whilst it could be argued that our analysis of those 
receiving pre-emptive transplant should include only those patients deemed eligible to 
undergo the procedure, by including all patients reaching ESKD we seek to reveal any 
bias in the process by which eligibility is determined. Our regression analysis, whereby 
baseline comorbidity is adjusted for, also seeks to account for this, and indeed there 
remains an independent association between SED and PET even after adjustment for 
comorbidities which may prove relative or absolute contraindications to 
transplantation.     
In conclusion, there is a discrepancy in the provision of pre-emptive and live donor 
transplantation in patients with socioeconomic deprivation. This is not accounted for 
by differences in the clinical characteristics at time of referral to nephrology services, 
the rate at which progression to ESKD occurs, and neither is the gap explained by the 
competing risk of death. With each increment in SIMD decile, there is a 14% increased 
likelihood of undergoing pre-emptive renal transplantation. Further research into the 
barriers of pre-emptive transplantation in patients from deprived backgrounds is 
required. Imaginative initiatives which improve access to, and knowledge of, renal 
transplantation should be a focus of the transplant community moving into the future.  
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Tables 
Table 1 
 Total 
n = 7765 
No ESKD 
n = 6467 
Other RRT 
n = 1185 
PET 
n = 113 
 
p value 
SIMD 4 ± 5 4 ± 5 4 ± 5 5 ± 7 0.003 
BMI (kg/m2) 28.5 ± 7.8 28.6 ± 7.6 27.7 ± 8.7 25.6 ± 6.6 0.003 
Referral creatinine (µmol/L) 163.3 ± 79.0 159.3 ± 70.3 199.0 ± 128.4 178.0 ± 157.7 <0.001 
Referral age (years) 68.9 ± 19.1 70.7 ± 17.2 58.4 ± 24.2 36.5 ± 19.5 <0.001 
Referral eGFR (ml/min/1.73m2) 36.7 ± 23.0 37.5 ± 22.3 30.6 ± 26.2 39.7 ± 39.8 0.001 
Referral BP (mmHg) 148/77 ± 34/19 147/76 ± 34/19 150/82 ± 34/18 138/82 ± 32/17 <0.001 
Referral uPCR (mg/mmol) 54.5 ± 140.4 43.8 ± 106.3 168.7 ± 326.4 93.2 ± 184.8 <0.001 
eGFR at RRT (ml/min/1.73m2) na na 7.04 ± 3.8 9.3 ± 5.7 <0.001 
Time to RRT (years) na na 4.9 ± 7.2 8.7 ± 12.1 <0.001 
Cardiovascular disease (%) 30 32 23 6 <0.001 
Diabetes (%) 36 37 37 15 <0.001 
Malignancy (%) 14 17 12 3 0.004 
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Charlson comorbidity index 5 ± 3 6 ± 3 4 ± 3 2 ± 1 <0.001 
Table 1 Baseline characteristics. P values refer to a comparison of patients receiving pre-emptive transplantation versus those receiving other 
modalities of renal replacement therapy. ESKD = End stage kidney disease, RRT = Renal replacement therapy, PET = Pre-emptive transplant, 
SIMD = Scottish Index of Multiple Deprivation, BMI = Body mass index, eGFR = Estimated glomerular filtration rate, uPCR = Urinary protein to 
creatinine ratio.
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Table 2 
 SIMD>3 
n = 4170 
SIMD≤3 
n = 3454 
 
p value 
SIMD 7 ± 4 2 ± 1 <0.001 
BMI (kg/m2) 28.1 ± 7.3 29.0 ± 8.4 <0.001 
Referral creatinine (µmol/L) 164.0 ± 79.7 162.7 ± 77.0 0.24 
Referral age (years) 69.3 ± 19.1 68.7 ± 19.0 0.02 
Referral eGFR (ml/min/1.73m2) 36.3 ± 23.1 37.0 ± 22.8 0.18 
Referral BP (mmHg) 148/78 ± 35/18 148/77 ± 34/19 0.69 
Referral uPCR (mg/mmol) 51.7 ± 130.4 57.0 ± 192.2 0.003 
Cardiovascular disease (%) 28 32 <0.001 
Diabetes (%) 35 38 0.001 
Malignancy (%) 17 15 0.01 
Charlson comorbidity index 5 ± 3 6 ± 3 0.98 
Hospital HD (%) 72 84 <0.001 
Home HD (%) 1 0.7 0.38 
Peritoneal dialysis (%) 17 9 <0.001 
Transplant (%) 10 6 0.02 
Live (%) 7 3 0.004 
Table 2 Baseline parameters of patients with SIMD decile less than or equal to three in 
comparison to the remainder of the cohort. The proportional uptake of each RRT modality 
refers to those patients reaching ESKD. BMI = Body mass index, eGFR = Estimated 
glomerular filtration rate, BP = Blood pressure, uPCR = Urinary protein to creatinine ratio, 
HD = Haemodialysis, SIMD = Scottish Index of Multiple Deprivation. 
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Table 3 
   CSH SHR 
Event Predictor Increment HR 95% CI HR 95% CI 
ESKD Female  1.00 0.89, 1.12 1.01 0.90, 1.14 
SIMD 1 0.99 0.97, 1.01 1.00 0.98, 1.02 
Cardiovascular disease  0.79 0.68, 0.90 0.85 0.73, 0.98 
Malignancy  0.76 0.64, 0.90 0.84 0.70, 0.99 
Diabetes  1.35 1.20, 1.52 1.18 1.05, 1.34 
Referral age (years) 10 0.72 0.69, 0.75 0.58 0.56, 0.60 
Referral eGFR (ml/min/1.73m2) 10 0.69 0.66, 0.71 0.75 0.72, 0.78 
Referral systolic BP (mmHg) 10 1.03 1.02, 1.04 1.03 1.02, 1.04 
 Referral uPCR (mg/mmol) 100 1.03 1.02, 1.03 1.04 1.02, 1.05 
Death Female  0.95 0.89, 1.03 0.97 0.90, 1.04 
SIMD 1 0.97 0.95, 0.98 0.97 0.96, 0.98 
Cardiovascular disease  1.22 1.13, 1.31 1.33 1.24, 1.43 
Malignancy  1.19 1.09, 1.30 1.25 1.14, 1.37 
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Table 3 Regression analysis of the covariables associated with progression to death or end stage kidney disease, by the cause specific hazards 
model, and Fine and Gray’s subdistribution hazards model. SIMD = Scottish Index of Multiple Deprivation, eGFR = Estimated glomerular 
filtration rate, BP = Blood pressure, uPCR = Urinary protein to creatinine ratio, CSH = Cause specific hazard, SHR = Subdistribution hazard ratio, 
ESKD = End stage kidney disease, HR = Hazard ratio.   
 
Diabetes  1.37 1.27, 1.47 1.45 1.07, 1.24 
Referral age (years) 10 2.23 2.14, 2.23 1.82 1.75, 1.89 
Referral eGFR (ml/min/1.73m2) 10 0.90 0.87, 0.92  0.99 0.96, 1.01 
Referral systolic BP (mmHg) 10 0.98 0.97, 0.99  0.98 0.96, 0.99 
 Referral uPCR (mg/mmol) 100 1.02 1.01, 1.02 1.01 1.00, 1.02 
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Table 4 
  
Variable Increment OR 95% CI p value 
SIMD 1 1.14 1.06, 1.23 <0.001 
Diabetes  0.56 0.31, 0.99 0.05 
Malignancy  0.28 0.08, 0.94 0.04 
Cardiovascular disease  0.54 0.24, 1.24 0.16 
Referral eGFR (ml/min/1.73m2) 10 0.88 0.82, 0.95 0.001 
Referral age (years) 10 0.57 0.49, 0.67 <0.001 
Referral systolic BP (mmHg) 10 0.95 0.87, 1.04 0.36 
Referral uPCR (mg/mmol) 100 0.84 0.75, 0.95 0.004 
SIMD 1 1.14 1.06, 1.23 <0.01 
Charlson comorbidity index 1 0.82 0.70, 0.97 0.02 
Referral eGFR (ml/min/1.73m2) 10 0.87 0.81, 0.94 <0.001 
Referral age (years) 10 0.59 0.49, 0.71 <0.001 
Referral systolic BP (mmHg) 10 0.96 0.87, 1.05 0.36 
Referral uPCR (mg/mmol) 100 0.84 0.75, 0.95 0.004 
Table 4 Multiple logistic regression analysis of the covariable influencing pre-emptive kidney transplantation. SIMD = Scottish Index of Multiple 
Deprivation, eGFR = Estimated glomerular filtration rate, BP = Blood pressure, uPCR = Urinary protein to creatinine 
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Legend to figures 
Figure 1 
Cumulative incidence curves demonstrating association between socioeconomic 
status and progression to end stage kidney disease or death. Produced with the cr17 
R package. ESKD = End stage kidney disease, SIMD = Scottish Index of Multiple 
Deprivation.  
Figure 2 
Forest plot of factors influencing likelihood of pre-emptive kidney transplant with 
specific comorbidities (A) and comorbidity index (B). SIMD = Scottish Index of Multiple 
Deprivation, eGFR = Estimated glomerular filtration rate, BP = blood pressure, uPCR 
= Urinary protein creatinine ratio, OR = Odds ratio, CI = Confidence interval.  
 
